1. Home
  2. RAIL vs TNXP Comparison

RAIL vs TNXP Comparison

Compare RAIL & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FreightCar America Inc.

RAIL

FreightCar America Inc.

HOLD

Current Price

$6.17

Market Cap

235.1M

Sector

Industrials

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$7.28

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAIL
TNXP
Founded
1901
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.1M
199.7M
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
RAIL
TNXP
Price
$6.17
$7.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$14.67
★ $44.50
AVG Volume (30 Days)
226.2K
★ 561.3K
Earning Date
11-09-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 134.94
91.75
EPS
★ 0.32
N/A
Revenue
★ $500,991,000.00
$13,107,000.00
Revenue This Year
N/A
$319.65
Revenue Next Year
$49.52
$101.60
P/E Ratio
$19.69
★ N/A
Revenue Growth
N/A
★ 29.85
52 Week Low
$6.24
$7.42
52 Week High
$14.90
$22.38

Technical Indicators

Market Signals
Indicator
RAIL
TNXP
Relative Strength Index (RSI) 30.58 15.19
Support Level N/A N/A
Resistance Level $7.55 $12.99
Average True Range (ATR) 0.27 0.55
MACD -0.09 -0.30
Stochastic Oscillator 5.91 0.95

Price Performance

Historical Comparison
RAIL
TNXP

About RAIL FreightCar America Inc.

FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: